AIZN Assurant, Inc. 5.25% Subordinated Notes due 2061
NYSE · Insurance · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 6, 2026AIZN Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
AIZN Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
O Assurant, Inc. 5.25% Subordinated Notes due 2061 Przegląd firmy z Wikipedii
Assurant, Inc. is a global provider of risk management products and services with headquarters in Atlanta. Its businesses provide a diverse set of speciality, niche-market insurance products in the property, casualty, extended device protection, and insurance sectors. The company's main operating segments are Global Housing and Global Lifestyle.
The company, formerly known as Fortis, Inc., was spun off from Dutch and Belgian financial-services company Fortis Insurance N.V. in 2004. The company's initial public offering on Feb. 5, 2004 at $1.76 billion was the fourth largest that year. In connection with the public offering, the company changed its name to Assurant, Inc.
Assurant is 325 on the Fortune 500 list of the largest companies in the United States by revenue as of 2022.
History
Assurant can trace its roots back to the founding of the La Crosse Mutual Aid Association, which was established to sell disability insurance in Wisconsin in the early 1890s. La Crosse Mutual Aid Association would later become the Time Insurance Company.
In 1978, N.V. AMEV of the Netherlands acquired the Time Insurance Company via its U.S. holding company AMEV Holdings, Inc. During the next 12 years, AMEV Holdings, Inc. would expand through acquisition, buying American Security Insurance (credit-related insurance); United Family (funeral insurance); Western Insurance Company (mutual funds); and Superior Insurance (auto insurance).
In 1990, N.V. AMEV of the Netherlands acquired VSB Groep NV bank to become the Netherlands first financial conglomerate combining an insurer and a bank, creating Fortis.
In 1991, AMEV acquired the group life, accident and health insurance of Mutual Benefit Life Insurance Company. AMEV Holdings, Inc. was rebranded Fortis, Inc. in 1991. Superior Insurance was sold in 1996. Fortis acquired John Alden in 1998 and American Bankers Insurance in 1999.
Fortis Inc. sold its life insurance to The Hartford in 2001. Fortis' American business was subsequently renamed as Assurant and spun off from the parent company in 2004.
On June 10, 2015, Assurant announced an exit from the health insurance marketplace to focus on housing and lifestyle specialty protection products and services, and would be winding down its Assurant Health business. In October 2015, Assurant announced it had completed the sale of Assurant Health's existing supplemental and self-funded business lines to National General Holdings Corporation. Assurant began to wind down its major medical operations and did not participate in the next Affordable Care Act open enrollment period beginning in November 2015. Assurant sold its HSA assets and other medical-account assets to SelectAccount in March 2016. In 2015 Assurant also announced it was exiting the employee benefits marketplace. Sun Life Financial agreed to acquire Assurant Employee Benefits for $940 million in September 2015, and closed the sale in March 2016.
Operations
Assurant operates six main segments:
Global Housing, which offers lender-placed insurance, renters insurance, manufactured home insurance, residential and commercial flood insurance, rental deposit alternatives, insurance tracking, and loss draft services.
Telecommunications, which offers mobile device protection services, service and repair contracts for mobile phones, tech support services, lifecycle and sustainability solutions, and a global network of physical repair locations. This division also works with wholesale buyers of pre-owned devices to promote circularity through its global network of device care centers that process roughly 20 million devices annually as well as through relationships with subsidiaries such as (but not limited to) Hyla Mobile.
Retail and Consumer Goods, for which the company is the largest U.S. protection provider across electronics, appliances, and jewelry. This division also administrates Assurant Home Warranty, sold exclusively through real estate agents.
Global Automotive, which works with Auto Dealers, dealer groups, and third-party administrators in the U.S. and directly with auto brands and OEMs internationally. For these groups, Assurant provides a full suite of Finance & Insurance (F&I) products that include GAP insurance, extended warranties, extended and pre-paid service and maintenance contracts, vehicle protection plans, hybrid and electric vehicle (EV) protection and service plans, and access to a preferred auto repair network. This division also provides dealership development performance coaching, training through the Automotive Training Academy, and profit participation/reinsurance programs for dealers.
Commercial Vehicles & Equipment, which serves industries including medium, heavy-duty, and light-duty trucking; leased and financed equipment for businesses, medical offices, restaurants and more; and equipment for forestry, agriculture, and construction companies. Products in this sector include vehicle protection and service contracts, insurance tracking, point-of-funding protection solutions, and liability protection.
Financial Services, which primarily focuses on added-value protection products and travel benefits for credit card providers and the nearly 61 million consumers they serve. Assurant also provides expertise in actuarial services, policy and claims administration, and compliance/regulatory oversight.
Assurant Health policy claim denials and cancellations
Assurant Health (now divested from Assurant) was repeatedly found to cancel health policies for some customers that had serious medical conditions, and 12 states criticized the firm for denying claims, with most of the states levying fines against Assurant. A number of individual cases have been reported.
In September 2009, the South Carolina Supreme Court upheld a lower court's verdict that the firm (then known as "Fortis") wrongly revoked the health insurance policy of a holder who had contracted HIV subsequent to getting an insurance policy, and ordered the firm to pay $10 million to the plaintiff. The court found that:
Pursuant to company policy in cases involving long-term disease, Fortis launched an investigation to determine whether [the plaintiff] had failed to disclose a pre-existing condition on his policy application...A Fortis investigator reviewed the records and discovered [an] erroneously-dated intake note in [the doctor’s] files. That information was then forwarded to [a] Fortis Senior Underwriter...for review. [The underwriter]...recommended that [the plaintiff’s] policy be rescinded on the grounds that he had misrepresented his HIV positive status.
A Reuters report on the ruling stated that Fortis had a company policy to target every recently diagnosed HIV-positive policyholder for an automatic fraud investigation as a pretext to rescind their policy, according to undisclosed records. As in that case, their insurance policies often were canceled on incorrect information, flimsy evidence, or for no reason at all. In March 2010, the U.S. Supreme Court rejected the firm's appeal of the ruling.
In February 2010, a Boulder, Colorado jury found that Assurant Health had breached its contract with a woman who was severely injured in a hit-and-run accident, and awarded her $183,551 for medical bills and approximately $37.1 million in punitive damages. This was described as "one of the largest bad-faith judgments in Colorado history".
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | AIZN | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 0.8średnia z 5 lat ≈1.9 | ≈1.9 | · | · | |
| P/S (TTM) | 0.1średnia z 5 lat ≈0.1 | ≈0.1 | · | · | |
| P/B (MRQ) | 0.1średnia z 5 lat ≈0.2 | ≈0.2 | · | · | |
| Cena / FCF (TTM) | 0.5średnia z 5 lat ≈1.6 | ≈1.6 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 0.5średnia z 5 lat ≈1.2 | ≈1.2 | · | · | |
| Cena / Wartość księgowa materialna (MRQ) | 0.2średnia z 5 lat ≈0.7 | ≈0.7 | · | · | |
| PEG Ratio (Współczynnik PEG) | ≈0.0 | · | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | AIZN | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| EBITDA Margin (Marża EBITDA) | 1.9%średnia z 5 lat ≈1.8% | ≈1.8% | · | · | |
| Marża przed opodatkowaniem (TTM) | 9.9%średnia z 5 lat ≈6.9% | ≈6.9% | · | · | |
| Marża Zysku Netto (TTM) | 7.9%średnia z 5 lat ≈7.0% | ≈7.0% | · | · | |
| ROA (TTM) | 3.0%średnia z 5 lat ≈2.2% | ≈2.2% | · | · | |
| ROE (TTM) | 18.3%średnia z 5 lat ≈14.9% | ≈14.9% | · | · |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Za mało danych fundamentalnych, aby obliczyć tę grupę wskaźników.
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | AIZN | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 7.9%średnia z 5 lat ≈6.0% | ≈6.0% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 7.9%średnia z 5 lat ≈6.1% | ≈6.1% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 5.9% | · | · | · | |
| EPS YoY | 17.1%średnia z 5 lat ≈64.3% | ≈64.3% | · | · | |
| Net Income YoY (Zysk Netto R/R) | 14.8%średnia z 5 lat ≈58.9% | ≈58.9% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | 49.7%średnia z 5 lat ≈18.5% | ≈18.5% | · | · | |
| EPS CAGR 5Y (CAGR z EPS 5 lat) | 19.4% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | 46.7%średnia z 5 lat ≈14.1% | ≈14.1% | · | · | |
| Net Income CAGR 5Y (CAGR z zysku netto 5 lat) | 14.6% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | AIZN | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.4średnia z 5 lat ≈0.3 | ≈0.3 | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
| Data ex-dywidendy | Kwota | Waluta | Stopa zwrotu |
|---|---|---|---|
| Lip 1, 2026 | $0,33 | USD | ≈7.0% |
| Kwi 1, 2026 | $0,33 | USD | ≈6.7% |
| Gru 31, 2025 | $0,33 | USD | ≈6.7% |
| Paź 1, 2025 | $0,33 | USD | ≈6.5% |
| Lip 1, 2025 | $0,33 | USD | ≈6.3% |
| Kwi 1, 2025 | $0,33 | USD | ≈6.8% |
| Gru 31, 2024 | $0,33 | USD | ≈6.5% |
| Paź 1, 2024 | $0,33 | USD | ≈5.9% |
| Lip 1, 2024 | $0,33 | USD | ≈6.4% |
| Mar 28, 2024 | $0,33 | USD | ≈5.8% |
| Gru 28, 2023 | $0,33 | USD | ≈6.6% |
| Wrz 28, 2023 | $0,33 | USD | ≈7.0% |
| Cze 29, 2023 | $0,33 | USD | ≈6.9% |
| Mar 30, 2023 | $0,33 | USD | ≈6.6% |
| Gru 29, 2022 | $0,33 | USD | ≈6.4% |
| Wrz 29, 2022 | $0,33 | USD | ≈6.2% |
| Cze 30, 2022 | $0,33 | USD | ≈5.9% |
| Mar 31, 2022 | $0,33 | USD | ≈5.7% |
| Gru 30, 2021 | $0,33 | USD | ≈5.7% |
| Wrz 30, 2021 | $0,33 | USD | ≈4.4% |
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | $6.41 | $5.23 | 22.5% | |
| 31 marca 2026 | $5.95 | $5.35 | 11.3% | |
| 31 grudnia 2025 | $5.61 | $5.56 | 0.94% | |
| 30 września 2025 | $5.73 | $4.32 | 32.7% | |
| 30 czerwca 2025 | $5.10 | $4.55 | 12.1% | |
| 31 marca 2025 | $3.39 | $2.78 | 22.0% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.81B | $11.88B | $11.13B | $10.19B | $10.19B | $9.60B | $9.57B | $8.06B | $6.42B | $7.53B | $10.33B | $10.38B | |
| SG&A Expense | · | · | · | · | $3.25B | $3.05B | $3.19B | $2.98B | $2.71B | $3.44B | $3.92B | $3.69B | |
| Interest Expense | · | · | $108M | $108M | $112M | $104M | $111M | $100M | $50M | $58M | $55M | $58M | |
| Pretax Income | $1.09B | $927M | $807M | $350M | $771M | $578M | $455M | $334M | $444M | $849M | $201M | $744M | |
| Income Tax | $215M | $167M | $164M | $73M | $168M | $59M | $148M | $81M | $-75M | $283M | $60M | $273M | |
| Net Income | $873M | $760M | $642M | $277M | $1.36B | $441M | $383M | $251M | $520M | $565M | $142M | $471M | |
| EPS (Basic) | $17.14 | $14.55 | $12.02 | $5.09 | $22.95 | $7.02 | $5.87 | $4.00 | $9.45 | $9.23 | $2.08 | $6.52 | |
| EPS (Diluted) | $16.93 | $14.46 | $11.95 | $5.05 | $22.66 | $6.98 | $5.84 | $3.98 | $9.39 | $9.13 | $2.05 | $6.44 | |
| Shares (Basic) | 50,469,633 | 51,703,588 | 52,870,380 | 54,371,531 | 59,140,861 | 60,114,670 | 61,942,969 | 59,239,608 | 54,986,654 | 61,261,288 | 68,163,825 | 72,181,447 | |
| Shares (Diluted) | 51,086,649 | 52,052,961 | 53,198,310 | 54,782,528 | 60,123,694 | 63,179,938 | 62,313,468 | 59,545,524 | 55,311,032 | 61,934,774 | 69,017,209 | 73,152,010 | |
| EBITDA | $250M | $224M | $196M | $182M | $172M | $144M | $126M | $127M | $116M | $125M | $137M | $132M |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.83B | $1.81B | $1.63B | $1.54B | $2.04B | $2.21B | $1.87B | $1.25B | $997M | $1.03B | $1.29B | $1.32B | |
| Short-term Investments | · | · | · | · | · | · | $402M | $373M | · | · | · | · | |
| PP&E (Net) | $842M | $768M | $686M | $645M | $561M | $446M | $434M | $392M | $348M | $344M | $298M | $278M | |
| PP&E (Gross) | $1.49B | $1.27B | $1.08B | $1.05B | $917M | $780M | $762M | $766M | $696M | $678M | $756M | $792M | |
| Accum. Depreciation | $649M | $501M | $393M | $407M | $356M | $334M | $328M | $374M | $349M | $334M | $458M | $515M | |
| Goodwill | $2.65B | $2.62B | $2.61B | $2.60B | $2.57B | $2.59B | $2.21B | $2.32B | $918M | $831M | $834M | $841M | |
| Intangibles | $522M | $536M | $567M | $639M | $719M | $696M | $540M | $622M | $289M | $240M | $277M | $382M | |
| Total Assets | $36.29B | $35.02B | $33.64B | $33.12B | $33.92B | $44.65B | $44.29B | $41.09B | $31.84B | $29.71B | $30.04B | $31.56B | |
| Total Liabilities | $30.42B | $29.91B | $28.83B | $28.89B | $28.46B | $38.70B | $38.61B | $35.96B | $27.56B | $25.61B | $25.51B | $26.38B | |
| Long-term Debt | · | · | · | · | · | · | $2.01B | $2.01B | $1.07B | · | · | · | |
| Common Stock | $500.0K | $500.0K | $600.0K | $600.0K | $700.0K | $600.0K | $2M | $2M | $2M | $2M | $1M | $1M | |
| Retained Earnings | $4.83B | $4.38B | $4.03B | $3.70B | $4.04B | $3.55B | $5.97B | $5.76B | $5.70B | $5.30B | $4.86B | $4.81B | |
| Treasury Stock | $123M | $123M | $123M | $123M | $123M | $267M | $5.27B | $4.99B | $4.86B | $4.47B | $3.60B | $3.32B | |
| AOCI | $-544M | $-836M | $-765M | $-986M | $-150M | $710M | $412M | $-155M | $234M | $95M | $119M | $556M | |
| Stockholders' Equity | $5.87B | $5.11B | $4.81B | $4.23B | $5.46B | $5.95B | $5.65B | $5.11B | $4.27B | $4.10B | $4.52B | $5.18B | |
| Liabilities + Equity | $36.29B | $35.02B | $33.64B | $33.12B | $33.92B | $44.65B | $44.29B | $41.09B | $31.84B | $29.71B | $30.04B | $31.56B | |
| Shares Outstanding | 49,792,919 | 50,833,749 | 51,955,994 | 52,830,381 | 55,754,113 | 57,967,808 | 59,945,893 | 61,908,979 | 52,417,812 | 55,941,480 | 65,850,386 | 69,299,559 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $250M | $224M | $196M | $182M | $172M | $142M | $126M | $127M | $116M | $125M | $137M | $132M | |
| Stock-based Comp | $86M | $81M | $75M | $63M | $67M | $58M | $56M | $57M | $36M | $42M | $39M | $49M | |
| Deferred Tax | $101M | $245M | $-108M | $64M | $132M | $202M | $101M | $21M | $-4M | $25M | $-4M | $64M | |
| Amort. of Intangibles | $109M | $98M | $98M | $94M | $89M | $74M | $62M | $78M | $73M | $68M | $72M | $64M | |
| Restructuring | · | · | · | · | · | · | · | $2M | $3M | $31M | $86M | · | |
| Other Non-cash | $524M | $23M | $333M | $12M | $-961M | $506M | $760M | $200M | $-136M | $-623M | $-59M | $-323M | |
| Operating Cash Flow | $1.83B | $1.33B | $1.14B | $597M | $782M | $1.34B | $1.41B | $657M | $530M | $109M | $230M | $394M | |
| CapEx | $236M | $221M | $202M | $186M | $187M | $121M | $110M | $83M | $62M | $85M | $115M | $84M | |
| Investing Cash Flow | $-1.46B | $-658M | $-638M | $-262M | $158M | $-735M | $-620M | $-2.20B | $-541M | $726M | $264M | · | |
| Debt Issued | · | · | · | $0 | $347M | $244M | $347M | $1.29B | $0 | $250M | $0 | $0 | |
| Net Debt Issued | · | · | $-225M | $-76M | $-73M | $244M | $-33M | $1.29B | $0 | $250M | $0 | $0 | |
| Stock Repurchased | $304M | $307M | $193M | $573M | $839M | $297M | $272M | $139M | $389M | $863M | $293M | $215M | |
| Net Stock Activity | $-304M | $-307M | $-193M | $-573M | $-839M | $-297M | $-272M | $-139M | $-389M | $-863M | $-293M | $-215M | |
| Dividends Paid | $168M | $156M | $152M | $150M | $158M | $155M | $151M | $134M | $119M | $125M | $94M | $77M | |
| Financing Cash Flow | $-364M | $-478M | $-404M | $-818M | $-1.09B | $-265M | $-179M | $1.84B | $-27M | $-1.08B | $-462M | · | |
| Net Change in Cash | $26M | $180M | $91M | $-518M | $-174M | $362M | $613M | $257M | $-35M | $-256M | $-30M | $-399M | |
| Taxes Paid | $272M | $127M | $233M | $128M | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.60B | $1.11B | $936M | $411M | $594M | $1.22B | $1.30B | $574M | $468M | $49M | $140M | $310M | |
| Levered FCF | · | · | $850M | $325M | $507M | $1.13B | $1.23B | $498M | $410M | $11M | $101M | $273M |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 6.8% | 6.4% | 5.8% | 2.7% | 13.5% | 4.4% | 3.8% | 3.1% | 8.1% | 7.5% | 1.4% | 4.5% | |
| Pretax Margin | 8.5% | 7.8% | 7.2% | 3.4% | 7.7% | 5.1% | 5.5% | 4.1% | 6.9% | 11.3% | 1.9% | 7.2% | |
| EBITDA Margin | 1.9% | 1.9% | 1.8% | 1.8% | 1.7% | 1.4% | 1.2% | 1.6% | 1.8% | 1.7% | 1.3% | 1.3% | |
| ROA | 2.5% | 2.2% | 1.9% | 0.83% | 3.5% | 0.99% | 0.90% | 0.69% | 1.7% | 1.9% | 0.46% | 1.5% | |
| ROE | 15.3% | 14.7% | 13.8% | 6.6% | 24.0% | 7.6% | 7.1% | 5.3% | 12.4% | 13.1% | 2.9% | 9.4% |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $117.92 | $100.46 | $92.57 | $80.04 | $98.46 | $102.67 | $94.30 | $82.57 | $81.47 | $73.26 | $68.70 | $74.77 | |
| Revenue / Share | $250.83 | $225.89 | $206.97 | $186.06 | $169.44 | $159.78 | $161.87 | $135.32 | $115.98 | $121.61 | $149.61 | $141.92 | |
| Cash Flow / Share | $35.90 | $25.35 | $21.16 | $10.90 | $13.00 | $21.24 | $22.68 | $11.03 | $9.59 | $2.17 | $3.69 | $5.38 | |
| Cash / Share | $36.83 | $35.56 | $31.32 | $29.09 | $36.60 | $38.45 | $31.15 | $20.26 | $19.02 | $18.45 | $19.56 | $19.03 | |
| Dividend / Share | $3.28 | $2.96 | $2.82 | $2.74 | $2.66 | $2.55 | $2.43 | $2.28 | $2.15 | $2.03 | · | · | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | $2.15 | $2.03 | $1.37 | $1.06 | |
| EPS (TTM) | $16.93 | $14.46 | $11.95 | $5.05 | $22.66 | $6.98 | $5.84 | $3.98 | $9.39 | $9.13 | $2.05 | $6.44 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.9% | 6.7% | 9.2% | 0.05% | 6.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.9% | 5.2% | 5.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 17.1% | 21.0% | 136.6% | -77.7% | 224.6% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 49.7% | -13.9% | 19.6% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 19.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 14.8% | 18.3% | 132.3% | -79.7% | 208.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 46.7% | -17.7% | 13.4% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 14.6% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 1.7% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $12.81B | $11.88B | $11.13B | $10.19B | $10.19B | $9.60B | $9.57B | $8.06B | $6.42B | $7.53B | $10.33B | $10.38B | |
| Net Income TTM | $873M | $760M | $642M | $277M | $1.36B | $441M | $383M | $251M | $520M | $565M | $142M | $471M | |
| Market Cap | $968M | $1.02B | $1.04B | $1.07B | $1.50B | $1.59B | · | · | · | · | · | · | |
| P/E | 1.1 | 1.4 | 1.7 | 4.0 | 1.2 | 3.9 | · | · | · | · | · | · | |
| P/S | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | · | · | · | · | · | · | |
| P/B | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | · | · | · | · | · | · | |
| P / Tangible Book | 0.4 | 0.5 | 0.6 | 1.1 | 0.7 | 0.6 | · | · | · | · | · | · | |
| P / Cash Flow | 0.5 | 0.8 | 0.9 | 1.8 | 1.9 | 1.2 | · | · | · | · | · | · | |
| P / FCF | 0.6 | 0.9 | 1.1 | 2.6 | 2.5 | 1.3 | · | · | · | · | · | · | |
| Dividend Yield | 17.4% | 15.3% | 14.7% | 14.1% | 10.5% | 9.8% | · | · | · | · | · | · | |
| Earnings Yield | 87.0% | 72.0% | 59.9% | 25.0% | 84.0% | 25.5% | · | · | · | · | · | · | |
| Payout Ratio | 19.3% | 20.5% | 23.7% | 54.3% | 11.5% | 35.0% | 39.6% | 53.3% | 22.9% | 22.2% | 66.5% | 16.5% | |
| Annual Payout | $168M | $156M | $152M | $150M | $158M | $155M | $151M | $134M | $119M | $125M | $94M | $77M |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.45B | $3.42B | $3.35B | $3.23B | $3.16B | $3.07B | $3.10B | $2.97B | $2.92B | $2.88B | $2.77B | $2.73B | $2.64B | $2.65B | $2.55B | $2.51B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $27M | $27M | $27M | $27M | · | $26M | $27M | |
| Pretax Income | $377M | $336M | $284M | $331M | $289M | $184M | $250M | $152M | $233M | $293M | $229M | $204M | $147M | $96M | $8M | $70M | |
| Income Tax | $78M | $62M | $58M | $66M | $54M | $37M | $49M | $18M | $44M | $56M | $39M | $48M | $34M | $28M | $1M | $18M | |
| Net Income | $299M | $274M | $225M | $266M | $235M | $147M | $201M | $134M | $189M | $236M | $190M | $156M | $114M | $68M | $7M | $52M | |
| EPS (Basic) | $5.98 | $5.47 | $4.46 | $5.22 | $4.60 | $2.86 | $3.90 | $2.56 | $3.59 | $4.50 | $3.55 | $2.91 | $2.12 | $1.32 | $0.14 | $0.96 | |
| EPS (Diluted) | $5.95 | $5.41 | $4.37 | $5.17 | $4.56 | $2.83 | $3.86 | $2.55 | $3.58 | $4.47 | $3.54 | $2.90 | $2.12 | $1.31 | $0.14 | $0.95 | |
| Shares (Basic) | 49,520,710 | 49,702,511 | · | 50,831,664 | 50,675,804 | 50,799,019 | · | 52,204,057 | 52,500,727 | 52,531,865 | 53,535,982 | 53,745,611 | 53,492,413 | · | 53,717,373 | 54,607,321 | |
| Shares (Diluted) | 49,831,416 | 50,197,547 | · | 51,320,491 | 51,112,351 | 51,248,716 | · | 52,464,522 | 52,717,736 | 52,872,254 | 53,745,173 | 53,889,682 | 53,698,162 | · | 54,066,605 | 55,014,947 | |
| EBITDA | · | $66M | · | · | · | $57M | · | · | · | $51M | · | · | $48M | · | · | · |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.70B | $1.59B | $1.83B | $1.71B | $1.49B | $1.67B | $1.81B | $1.81B | $1.71B | $1.28B | $1.43B | $1.40B | $1.53B | · | $1.43B | $1.18B | |
| PP&E (Net) | $850M | $849M | $842M | $831M | $812M | $786M | $768M | $742M | $733M | $706M | $664M | $643M | $671M | · | $618M | $609M | |
| PP&E (Gross) | · | · | $1.49B | · | · | · | $1.27B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $649M | · | · | · | $501M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $2.66B | $2.65B | $2.65B | $2.65B | $2.63B | $2.62B | $2.62B | $2.63B | $2.62B | $2.61B | $2.61B | $2.61B | $2.60B | $2.60B | $2.55B | $2.56B | |
| Intangibles | $488M | $511M | $522M | $528M | $530M | $552M | $536M | $546M | $555M | $563M | $590M | $608M | $616M | · | $631M | $676M | |
| Total Assets | $36.08B | $35.77B | $36.29B | $35.78B | $35.53B | $34.99B | $35.02B | $35.33B | $33.77B | $33.23B | $33.21B | $33.10B | $32.92B | · | $33.25B | $31.73B | |
| Total Liabilities | $29.98B | $29.90B | $30.42B | $30.02B | $30.03B | $29.75B | $29.91B | $30.08B | $28.77B | $28.31B | $28.72B | $28.62B | $28.52B | · | $29.15B | $27.27B | |
| Common Stock | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $600.0K | $600.0K | $600.0K | $600.0K | · | $600.0K | $600.0K | |
| Retained Earnings | $5.13B | $4.95B | $4.83B | $4.73B | $4.57B | $4.43B | $4.38B | $4.32B | $4.31B | $4.19B | $3.99B | $3.88B | $3.78B | · | $3.68B | $3.77B | |
| Treasury Stock | $123M | $123M | $123M | $123M | $123M | $123M | $123M | $123M | $123M | $123M | $123M | $123M | $123M | · | $123M | $123M | |
| AOCI | $-600M | $-629M | $-544M | $-547M | $-635M | $-748M | $-836M | $-627M | $-853M | $-811M | $-1.05B | $-923M | $-900M | · | $-1.08B | $-822M | |
| Stockholders' Equity | $6.10B | $5.87B | $5.87B | $5.76B | $5.50B | $5.23B | $5.11B | $5.26B | $5.00B | $4.92B | $4.49B | $4.49B | $4.40B | $4.23B | $4.10B | $4.46B | |
| Liabilities + Equity | $36.08B | $35.77B | $36.29B | $35.78B | $35.53B | $34.99B | $35.02B | $35.33B | $33.77B | $33.23B | $33.21B | $33.10B | $32.92B | · | $33.25B | $31.73B | |
| Shares Outstanding | 49,382,180 | 49,671,167 | 49,792,919 | 50,197,571 | 50,531,216 | 50,818,556 | 50,833,749 | 51,376,203 | 51,843,450 | 52,023,052 | 52,737,924 | 53,008,641 | 53,133,956 | 52,830,381 | 52,891,708 | 53,261,408 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $68M | $66M | $72M | $62M | $59M | $57M | $64M | $58M | $50M | $51M | $46M | $47M | $48M | $42M | $45M | $48M | |
| Stock-based Comp | $26M | $18M | $25M | $23M | $22M | $15M | $23M | $24M | $20M | $14M | $24M | $17M | $12M | $15M | $18M | $17M | |
| Other Non-cash | · | $-118M | · | · | · | $174M | · | · | · | $-219M | · | · | $85M | · | · | · | |
| Operating Cash Flow | $454M | $240M | $671M | $505M | $266M | $392M | $103M | $436M | $711M | $82M | $330M | $185M | $260M | $277M | $648M | $173M | |
| CapEx | $45M | $48M | $59M | $63M | $60M | $53M | $68M | $47M | $55M | $51M | $50M | $49M | $48M | $52M | $47M | $46M | |
| Investing Cash Flow | $-224M | $-282M | $-404M | $-270M | $-363M | $-422M | $71M | $-207M | $-193M | $-328M | $-157M | $-254M | $-229M | $-127M | $-242M | $120M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | $173M | · | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | $173M | · | · | · | |
| Stock Repurchased | $78M | $124M | $94M | $82M | $63M | $64M | $120M | $99M | $42M | $46M | $49M | $18M | $0 | $15M | $91M | $237M | |
| Net Stock Activity | · | $-124M | · | · | · | $-64M | · | · | · | $-46M | · | · | $0 | · | · | · | |
| Dividends Paid | $48M | $44M | $44M | $41M | $43M | $41M | $41M | $38M | $40M | $37M | $37M | $40M | $37M | $38M | $37M | $39M | |
| Financing Cash Flow | $-123M | $-203M | $-136M | $-5M | $-104M | $-119M | $-160M | $-141M | $-81M | $-96M | $-142M | $-57M | $-43M | $-51M | $-142M | $-347M | |
| Net Change in Cash | $107M | $-242M | $122M | $226M | $-183M | $-138M | $-6M | $100M | $431M | $-346M | $24M | $-124M | $-11M | $107M | $248M | $-77M | |
| Free Cash Flow | · | $193M | · | · | · | $339M | · | · | · | $32M | · | · | $211M | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $10M | · | · | $190M | · | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 8.6% | 8.0% | · | 8.2% | 7.4% | 4.8% | · | 4.5% | 6.5% | 8.2% | 6.9% | 5.7% | 4.3% | · | 0.29% | 2.1% | |
| Pretax Margin | 10.9% | 9.8% | · | 10.2% | 9.2% | 6.0% | · | 5.1% | 8.0% | 10.2% | 8.2% | 7.5% | 5.6% | · | 0.33% | 2.8% | |
| EBITDA Margin | · | 1.9% | · | · | · | 1.8% | · | · | · | 1.8% | · | · | 1.8% | · | · | · | |
| ROA | 0.83% | 0.77% | · | 0.75% | 0.68% | 0.43% | · | 0.39% | 0.56% | 0.71% | 0.57% | 0.48% | 0.34% | · | 0.02% | 0.13% | |
| ROE | 5.1% | 4.9% | · | 4.8% | 4.5% | 2.9% | · | 2.8% | 4.0% | 5.1% | 4.4% | 3.5% | 2.4% | · | 0.15% | 1.0% |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $123.48 | $118.17 | · | $114.72 | $108.81 | $103.00 | · | $102.29 | $96.53 | $94.57 | $85.15 | $84.63 | $82.74 | · | $77.50 | $83.73 | |
| Revenue / Share | $69.32 | $68.13 | · | $62.97 | $61.24 | $59.42 | · | $56.57 | $55.48 | $54.47 | $51.62 | $50.69 | $49.22 | · | $47.12 | $45.62 | |
| Cash Flow / Share | · | $4.79 | · | · | · | $7.59 | · | · | · | $1.56 | · | · | $4.83 | · | · | · | |
| Cash / Share | $34.40 | $32.04 | · | $34.12 | $29.42 | $32.85 | · | $35.30 | $33.04 | $24.64 | $27.03 | $26.44 | $28.71 | · | $27.03 | $22.19 | |
| Dividend / Share | $0.88 | $0.88 | $0.88 | $0.80 | $0.80 | $0.80 | $0.80 | $0.72 | $0.72 | $0.72 | $0.70 | $0.70 | $0.70 | $0.70 | $0.68 | $0.68 | |
| EPS (TTM) | $20.90 | $19.51 | · | $16.42 | $13.80 | $12.82 | · | $13.99 | $14.98 | $14.30 | $9.87 | $6.47 | $4.52 | · | $5.61 | $20.26 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.46B | $13.16B | · | $12.57B | $12.30B | $12.07B | · | $11.76B | $11.56B | $11.37B | $10.80B | $10.57B | $10.35B | · | $10.12B | $10.21B | |
| Net Income TTM | $1.06B | $1.00B | · | $849M | $717M | $670M | · | $741M | $798M | $765M | $528M | $345M | $241M | · | $322M | $1.19B | |
| Market Cap | $938M | $988M | · | $1.01B | $1.08B | $976M | · | $1.15B | $1.08B | $1.19B | $1.03B | $1000M | $1.04B | · | $1.13B | $1.19B | |
| P/E | 0.9 | 1.0 | · | 1.2 | 1.6 | 1.5 | · | 1.6 | 1.4 | 1.6 | 2.0 | 2.9 | 4.3 | · | 3.8 | 1.1 | |
| P/S | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| P/B | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | |
| P / Tangible Book | 0.3 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | 0.8 | 0.8 | 0.9 | · | 1.2 | 1.0 | |
| P / Cash Flow | · | 4.1 | · | · | · | 2.5 | · | · | · | 14.4 | · | · | 4.0 | · | · | · | |
| Dividend Yield | 18.8% | 17.3% | · | 16.4% | 15.0% | 16.3% | · | 13.3% | 14.1% | 12.9% | 14.7% | 15.1% | 14.4% | · | 13.5% | 13.0% | |
| Earnings Yield | 110.0% | 98.0% | · | 81.8% | 64.3% | 66.7% | · | 62.3% | 71.6% | 62.7% | 50.6% | 34.3% | 23.2% | · | 26.4% | 91.1% | |
| Payout Ratio | · | 16.1% | · | · | · | 27.9% | · | · | · | 15.8% | · | · | 32.6% | · | · | · | |
| Annual Payout | $177M | $172M | · | $165M | $162M | $159M | · | $153M | $153M | $153M | $151M | $151M | $150M | · | $152M | $154M |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $12.81B | $11.88B | $11.13B | $10.19B | $10.19B |
| Zysk netto | $873M | $760M | $642M | $277M | $1.36B |
| Rozwodniony EPS | $16.93 | $14.46 | $11.95 | $5.05 | $22.66 |
Zbyt mało danych fundamentalnych, aby utworzyć to sprawozdanie.
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $1.60B | $1.11B | $936M | $411M | $594M |
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| TPG Advisors VI-AIV, Inc., David Bonderman, James G. Coulter | 25 marca 2019 | · | Pierwotne zgłoszenie | Struktura kapitałowa | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 19 insiderów · 9 dyrektorzy generalni · 10 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Keith Demmings | President and CEO | 16 marca 2026 A | 136 635 | 0 | 2 | $-3 026 658 |
| Keith Meier | EVP, Chief Financial Officer | 15 maja 2026 S | 18 552 | 0 | 1 | $-6 357 750 |
| Campbell Michael P. | EVP, COO | 16 marca 2026 A | 27 443 | 0 | 0 | $0 |
| Robert Lonergan | EVP, CSTO | 22 czerwca 2026 S | 27 374 | 0 | 1 | $-1 838 970 |
| Dimitry Dirienzo | SVP, CAO, Controller | 26 maja 2026 S | 2 741 | 0 | 2 | $-669 595 |
| Jay Rosenblum | EVP, Chief Legal Officer | 14 maja 2026 S | 12 764 | 0 | 1 | $-503 540 |
| Subhashish Sengupta | EVP, Chief People Officer | 1 kwietnia 2026 F | 2 746 | 0 | 2 | $-400 096 |
| Ryan Lumsden | EVP, Pres, Global Housing | 1 kwietnia 2026 F | 17 298 | 0 | 0 | $0 |
| Jeffrey A. Strickland | EVP, Pres. Global Automotive | 16 marca 2026 A | 5 996 | 0 | 0 | $0 |
| Rajiv Basu | Dyrektor | 22 maja 2026 A | 3 731 | 0 | 0 | $0 |
| Lynn S. Blake | Dyrektor | 22 maja 2026 A | 668 | 0 | 0 | $0 |
| Ognjen Redzic | Dyrektor | 22 maja 2026 A | 8 136 | 0 | 0 | $0 |
| Sari Beth Granat | Dyrektor | 22 maja 2026 A | 4 624 | 0 | 0 | $0 |
| Kevin M Warren | Dyrektor | 22 maja 2026 A | 2 315 | 0 | 0 | $0 |
| Braxton J Carter II | Dyrektor | 22 maja 2026 A | 8 961 | 0 | 0 | $0 |
| Elaine Rosen | Dyrektor | 22 maja 2026 A | 27 686 | 0 | 0 | $0 |
| Harriet Edelman | Dyrektor | 22 maja 2026 A | 11 114 | 0 | 0 | $0 |
| Paul J Reilly | Dyrektor | 22 maja 2026 A | 22 155 | 0 | 0 | $0 |
| Biju Nair | · | 6 sierpnia 2026 S | 24 247 | 0 | 1 | $-1 188 970 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 1 fundusz ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| FPE · First Trust Exchange-Traded Fund III | 0,24% | 781 216 NS | 31 lipca 2026 | N-PORT |
AIZN Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| AIZN | $968M | 1.1 | 7.9% | 6.8% | 15.3% | · |
| HIG | $38.16B | 10.3 | 6.9% | 13.5% | 21.4% | · |
| WRB | $26.45B | 15.8 | 7.8% | 12.1% | 19.7% | · |
| CINF | $25.38B | 10.8 | 11.4% | 18.9% | 16.0% | · |
| L | · | 13.2 | 5.4% | 9.0% | 9.3% | · |
| MKL | $27.06B | 12.7 | 4.7% | 13.6% | 11.9% | · |
| AIZ | · | · | · | · | · | · |
| CNA | $12.92B | 10.2 | 5.0% | 8.5% | 11.6% | · |
| AFG | $11.40B | 13.6 | -1.8% | 10.3% | 18.1% | · |
| FNF | $14.79B | 24.7 | 5.6% | 4.2% | 7.9% | · |
| ERIE | · | · | 7.2% | 13.8% | 25.0% | · |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.